Literature DB >> 27459267

Association of inflammatory bowel disease with ankylosing spondylitis and rheumatoid arthritis: A nationwide population-based study.

Jung Min Bae1, Ji Yoon Choo1, Ki-Jo Kim2, Kyung-Su Park2.   

Abstract

OBJECTIVES: Tantalizing connections between autoimmune rheumatic diseases (ARDs) and inflammatory bowel disease (IBD) have become evident with regard to their genetic and immunologic background. However, the association between these two disease entities remains unclear. The aim of this study is to investigate the association between each ARD and IBD.
METHODS: A nationwide population-based cross-sectional study was performed using the Korean National Health Insurance Claims database. The data of patients with IBD and age- and sex-matched controls between 2009 and 2013 were collected from the database. The prevalence of ARDs, including systemic lupus erythematosus (SLE), inflammatory myositis (polymyositis and dermatomyositis), systemic sclerosis (SSc), Sjögren's syndrome (SjS), ankylosing spondylitis (AS), and rheumatoid arthritis (RA), was determined. The associations between each ARD and IBD were analyzed using multivariate logistic regression models.
RESULTS: A total of 40,843 IBD patients (28,197 patients with ulcerative colitis and 12,646 with Crohn's disease) and 122,529 controls were enrolled. The nonstratified analysis revealed that patients with IBD had significant risk of being concomitantly affected by AS (odds ratio [OR] 5.140, 95% confidence interval [95% CI] 4.069-6.492) and RA (OR: 3.474, 95% CI: 2.671-4.519) after adjusting for age and sex. No significant association was observed between IBD and other ARDs including SLE, inflammatory myositis, SSc, and SjS.
CONCLUSION: IBD is significantly associated with AS and RA in the large-scaled population-based study. This result suggests that etiopathogenesis of IBD might be shared with AS and RA.

Entities:  

Keywords:  Ankylosing spondylitis; Inflammatory bowel disease; Rheumatoid arthritis

Mesh:

Year:  2016        PMID: 27459267     DOI: 10.1080/14397595.2016.1211229

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  17 in total

1.  Comorbidities As Risk Factors for Rheumatoid Arthritis and Their Accrual After Diagnosis.

Authors:  Vanessa L Kronzer; Cynthia S Crowson; Jeffrey A Sparks; Elena Myasoedova; John M Davis
Journal:  Mayo Clin Proc       Date:  2019-11-20       Impact factor: 7.616

Review 2.  The gut-joint axis in rheumatoid arthritis.

Authors:  Mario M Zaiss; Hsin-Jung Joyce Wu; Daniele Mauro; Georg Schett; Francesco Ciccia
Journal:  Nat Rev Rheumatol       Date:  2021-03-05       Impact factor: 32.286

3.  Plasma, urine and ligament tissue metabolite profiling reveals potential biomarkers of ankylosing spondylitis using NMR-based metabolic profiles.

Authors:  Wei Wang; Gen-Jin Yang; Ju Zhang; Chen Chen; Zhen-Yu Jia; Jia Li; Wei-Dong Xu
Journal:  Arthritis Res Ther       Date:  2016-10-22       Impact factor: 5.156

Review 4.  Status of etoricoxib in the treatment of rheumatic diseases. Expert panel opinion.

Authors:  Brygida Kwiatkowska; Maria Majdan; Agnieszka Mastalerz-Migas; Maciej Niewada; Barbara Skrzydło-Radomańska; Artur Mamcarz
Journal:  Reumatologia       Date:  2017-12-30

5.  Dissecting the Underlying Pharmaceutical Mechanism of Chinese Traditional Medicine Yun-Pi-Yi-Shen-Tong-Du-Tang Acting on Ankylosing Spondylitis through Systems Biology Approaches.

Authors:  Duoli Xie; Lin Huang; Guanghui Zhao; Yiran Yu; Jiawei Gao; Haichang Li; Chengping Wen
Journal:  Sci Rep       Date:  2017-10-18       Impact factor: 4.379

6.  The risk of rheumatoid arthritis among patients with inflammatory bowel disease: a systematic review and meta-analysis.

Authors:  Yi Chen; Lang Chen; Changsheng Xing; Guangtong Deng; Furong Zeng; Tingting Xie; Lei Gu; Huixiang Yang
Journal:  BMC Gastroenterol       Date:  2020-06-17       Impact factor: 3.067

7.  Risk of immune-mediated inflammatory diseases in newly diagnosed ankylosing spondylitis patients: a population-based matched cohort study.

Authors:  Hsin-Hua Chen; Wen-Cheng Chao; Yi-Hsing Chen; Tsu-Yi Hsieh; Kuo-Lung Lai; Yi-Ming Chen; Wei-Ting Hung; Ching-Tsai Lin; Chih-Wei Tseng; Ching-Heng Lin
Journal:  Arthritis Res Ther       Date:  2019-08-29       Impact factor: 5.156

8.  Inflammatory arthritis disrupts gut resolution mechanisms, promoting barrier breakdown by Porphyromonas gingivalis.

Authors:  Magdalena B Flak; Romain A Colas; Estefanía Muñoz-Atienza; Michael A Curtis; Jesmond Dalli; Costantino Pitzalis
Journal:  JCI Insight       Date:  2019-07-11

9.  Family History of Rheumatic, Autoimmune, and Nonautoimmune Diseases and Risk of Rheumatoid Arthritis.

Authors:  Vanessa L Kronzer; Cynthia S Crowson; Jeffrey A Sparks; Elena Myasoedova; John Davis
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-02       Impact factor: 4.794

10.  Subclinical sacroiliitis detected by abdominopelvic computed tomography in Korean patients with Crohn's disease.

Authors:  You-Jung Ha; Hyo Jin Kim; Eugene Lee; Ji Hye Park; Young Soo Park; Yun Jong Lee; Yusuhn Kang; Hyuk Yoon
Journal:  Korean J Intern Med       Date:  2021-03-22       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.